NCT02958592
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
Not specified
Clinical trial condition
Carcinoma, Hepatocellular
Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.
2,099 public trials
531 recruiting studies
Carcinoma, Hepatocellular trial results
Completed
Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)
NCT01078415
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Hopital Beaujon Paris, France
- L'institut de cancerologie Gustave Roussy Villejuif, Île-de-France Region, France
- Universitatsklinikum Magdeburg AoR, Klinik fur Radiologie und Nuklearmedizin Magdeburg, Germany
- University of Pisa School of Medicine Pisa, Tuscany, Italy
NCT01897038
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Sarasota, Florida, United States
- Baltimore, Maryland, United States
- New York, United States
- Nashville, Tennessee, United States
NCT02576964
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Beijing, China
- Guangzhou, China
- Kueishan, Taiwan
- Tainan, Taiwan
NCT01308723
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Singapore
- Singapore
NCT02941861
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
- Locations
-
Not specified
NCT00812175
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Many Locations, Alabama, United States
- Many Locations, Arizona, United States
- Many Locations, Arkansas, United States
- Many Locations, California, United States
NCT02928237
- Conditions
- Abdominal Pain, Adenocarcinoma, Agnosia, +18 more
- Locations
-
Not specified
NCT00508001
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Research Site Tainan, Taiwan
- Research Site Taipei, Taiwan
- Research Site Taoyuan, Taiwan
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States